The goal of this clinical research study is to compare armodafinil, bupropion, and
minocycline when given alone or in combination. Researchers want to learn about the safety
and level of effectiveness of these drugs in controlling symptoms, such as the side effects
of chemoradiation, when given to patients with head and neck cancer.